AH Bio Fund I L.P. 13D/13G Filings for CAMP4 Therapeutics Corporation (CAMP)

AH Bio Fund I L.P. 13D and 13G filings for CAMP4 Therapeutics Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-10-22
4:19 pm
Purchase
2024-10-15 13G CAMP4 Therapeutics Corporation
CAMP
AH Bio Fund I L.P. 2,125,339
10.900%
2,125,339increase
(New Position)
Filing